Cancer specific survival in patients with sickle cell disease
- PMID: 30467842
- PMCID: PMC8966490
- DOI: 10.1111/bjh.15687
Cancer specific survival in patients with sickle cell disease
Abstract
Sickle cell disease (SCD) patients have a higher incidence of certain cancers, but no studies have determined the impact of cancer on survival among SCD patients. SCD patients (n = 6423), identified from state-wide hospitalisation data, were linked to the California Cancer Registry (1988-2014). Multivariable Cox proportional hazards regression was used to examine survival. Among SCD patients, a cancer diagnosis was associated with a 3-fold increased hazard of death. Compared to matched cancer patients without SCD, SCD was associated with worse overall survival, but not cancer-specific survival, suggesting that SCD cancer patients should be treated with similar therapeutic intent.
Keywords: Sickle cell disease; cancer; epidemiology; survival.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.
Figures
References
-
- Allison PD (2010) Survival Analysis Using SAS: A Practical Guide.
-
- Brant Mary HD, Kairon Rajiv S (2017) California Cancer Reporting System Standards:Abstracting and Coding Procedures for Hospitals, vol I. Sacramento, CA.
-
- Brunson A, Lei A, Rosenberg AS, White RH, Keegan T & Wun T (2017b) Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol, 178, 319–326. - PubMed